Étude rétrospective multicentrique de 15 cas adultes de xanthomatose cérébrotendineuse : aspects cliniques et paracliniques typiques et atypiques

[1]  A. Giorgio,et al.  Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation , 2012, Neuroradiology.

[2]  S. Vukusic,et al.  Leukodystrophy with a cerebellar cystic aspect and intracranial atherosclerosis: an atypical presentation of cerebrotendinous xanthomatosis , 2012, Journal of Neurology.

[3]  F. Grandas,et al.  Neurophysiological study in cerebrotendinous xanthomatosis , 2011, Muscle & nerve.

[4]  D. Hannequin,et al.  Clinical imaging and neuropathological correlations in an unusual case of cerebrotendinous xanthomatosis. , 2010, Clinical neuropathology.

[5]  B. Fontaine,et al.  Leucoencéphalopathies génétiques de l’adulte , 2005 .

[6]  J. Fink,et al.  Cerebrotendinous xanthomatosis: possible higher prevalence than previously recognized. , 2005, Archives of neurology.

[7]  A. Federico,et al.  Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. , 2001, Brain : a journal of neurology.

[8]  F. Gabreëls,et al.  Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. , 2000, Radiology.

[9]  F. Gabreëls,et al.  Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. , 2000, Brain : a journal of neurology.

[10]  F. Gabreëls,et al.  Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis. , 2000, Archives of neurology.

[11]  F. Gabreëls,et al.  Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. , 1999, Brain : a journal of neurology.

[12]  F. Gabreëls,et al.  Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. , 1999, Metabolism: clinical and experimental.

[13]  J. Cruysberg,et al.  Treatment and follow-up of children with cerebrotendinous xanthomatosis , 1998, European Journal of Pediatrics.

[14]  G. Guazzi,et al.  Cerebrotendinous xanthomatosis (van Bogaert-Scherer-Epstein disease): CT and MR findings. , 1994, AJNR. American journal of neuroradiology.

[15]  V. Meiner,et al.  Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. , 1993, The Journal of clinical investigation.

[16]  L. Prockop,et al.  Magnetic resonance imaging of the brain and spinal cord in cerebrotendinous xanthomatosis. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[17]  S. Shefer,et al.  Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. , 1984, The New England journal of medicine.

[18]  G. Salen,et al.  Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis. , 1975, Biochemical medicine.